Endothelial dysfunction, arterial stiffness, and heart failure

Area of Science:

• Cardiovascular Medicine
• Physiology

Background:

• Suboptimal outcomes persist for heart failure (HF) patients, with recent trials yielding negative or neutral results.
• Existing therapies often improve surrogate markers but not necessarily patient mortality or clinical outcomes.
• A deeper understanding of HF pathophysiology is needed to translate therapeutic advancements into clinical benefits.

Purpose of the Study:

• To highlight the central role of vascular function in the development and progression of heart failure.
• To identify endothelial function and arterial stiffness as key physiological targets for novel HF therapies.
• To explore the potential of targeting vascular function for improved patient selection and application of existing treatments.

Main Methods:

• Review of current literature on heart failure pathophysiology and vascular function.
• Analysis of the impact of endothelial function and nitric oxide on myocardial and circulatory systems.
• Examination of the relationship between arterial stiffness and ventricular loading conditions in HF with preserved ejection fraction.

Main Results:

• Endothelial dysfunction and impaired nitric oxide availability negatively affect myocardial function and hemodynamics.
• Arterial stiffness significantly influences ventricular loading and diastolic function, particularly in HF with preserved ejection fraction.
• Vascular parameters demonstrate potential as physiological targets for therapeutic intervention in HF.

Conclusions:

• Improved understanding of vascular pathophysiology is essential for advancing heart failure treatment.
• Endothelial function and arterial stiffness represent promising targets for developing new heart failure therapies.
• Targeting vascular function may enhance the efficacy of existing treatments and improve patient stratification.